|
JPS4927290B1
(enExample)
|
1969-08-05 |
1974-07-16 |
|
|
|
US4071618A
(en)
|
1974-09-03 |
1978-01-31 |
Research Foundation For Microbial Diseases Of Osaka University |
Process for preparing virus disease live vaccines
|
|
JPS57136528A
(en)
|
1981-02-09 |
1982-08-23 |
Hayashibara Biochem Lab Inc |
Preparation of viral vaccine
|
|
NZ219515A
(en)
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US5786199A
(en)
|
1989-08-28 |
1998-07-28 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US5840520A
(en)
|
1989-08-28 |
1998-11-24 |
Aviron |
Recombinant negative strand RNA virus expression systems
|
|
US5919676A
(en)
|
1993-06-24 |
1999-07-06 |
Advec, Inc. |
Adenoviral vector system comprising Cre-loxP recombination
|
|
JP3484215B2
(ja)
|
1994-01-27 |
2004-01-06 |
花王株式会社 |
チャイニーズハムスター卵巣細胞変異株
|
|
US5750394A
(en)
|
1994-05-20 |
1998-05-12 |
The Mount Sinai Medical Center |
Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
|
|
CA2149197A1
(en)
|
1994-06-17 |
1995-12-18 |
Irene Popiel |
Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture
|
|
ES2210273T5
(es)
|
1994-07-18 |
2010-03-29 |
Conzelmann, Karl-Klaus, Prof. Dr. |
Virus con arn de cadena negativa no segmentado recombinante infeccioso.
|
|
EP0700991A1
(en)
|
1994-09-12 |
1996-03-13 |
Bayer Corporation |
Commercial scale concentrated preharvest tissue culture produced live T. Gondii bradyzoite and products and processes
|
|
WO1996010631A1
(en)
|
1994-09-30 |
1996-04-11 |
St. Jude Children's Research Hospital |
Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus
|
|
EP0704533A1
(en)
|
1994-09-30 |
1996-04-03 |
Bayer Ag |
An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus
|
|
US5716821A
(en)
|
1994-09-30 |
1998-02-10 |
Uab Research Foundation |
Prevention and treatment of respiratory tract disease
|
|
WO1996010400A1
(en)
|
1994-09-30 |
1996-04-11 |
The Uab Research Foundation |
Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
|
|
US6843996B1
(en)
|
1995-06-05 |
2005-01-18 |
Medimmune Vaccines, Inc. |
Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation
|
|
EP0780475B2
(en)
|
1995-08-09 |
2006-07-19 |
SCHWEIZ. SERUM- & IMPFINSTITUT BERN |
Process for the production of infectious negative-strand RNA viruses
|
|
US6037348A
(en)
|
1996-02-09 |
2000-03-14 |
Eli Lilly And Company |
Inhibition of viral replication
|
|
DE19612967A1
(de)
|
1996-04-01 |
1997-10-02 |
Behringwerke Ag |
Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
|
|
DE19612966B4
(de)
|
1996-04-01 |
2009-12-10 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
|
|
US5994526A
(en)
|
1996-06-21 |
1999-11-30 |
Plant Genetic Systems |
Gene expression in plants
|
|
WO1998002530A1
(en)
|
1996-07-15 |
1998-01-22 |
The Government Of The United States Of America, As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US6271011B1
(en)
|
1996-10-15 |
2001-08-07 |
The University Of Georgia Research Foundation, Inc. |
Pasteurella neuraminidase coding sequences and diagnostic methods
|
|
TW570803B
(en)
|
1997-04-09 |
2004-01-11 |
Duphar Int Res |
Influenza vaccine
|
|
WO1998048834A1
(en)
|
1997-04-30 |
1998-11-05 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
|
|
CN1250725C
(zh)
|
1997-05-23 |
2006-04-12 |
美国政府健康及人类服务部 |
从克隆的核苷酸序列制备减毒副流感病毒疫苗的方法
|
|
WO1999007839A2
(en)
|
1997-08-05 |
1999-02-18 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
Immunoprotective influenza antigen and its use in vaccination
|
|
US6169175B1
(en)
|
1997-08-06 |
2001-01-02 |
Centers For Disease Control And Prevention |
Preparation and use of recombinant influenza A virus M2 construct vaccines
|
|
US20020010143A1
(en)
|
1997-09-26 |
2002-01-24 |
Miguel S. Barbosa |
Compositions and methods for the treatment of human cytomegalovirus infection
|
|
KR100281676B1
(ko)
|
1997-11-29 |
2001-04-02 |
신동권 |
신규한독감생백신바이러스
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
|
US6270958B1
(en)
|
1998-10-29 |
2001-08-07 |
Washington University |
Detection of negative-strand RNA viruses
|
|
CA2364934C
(fr)
|
1999-02-22 |
2011-10-18 |
Transgene S.A. |
Procede d'obtention d'une preparation virale purifiee
|
|
EP1035209A1
(en)
|
1999-03-06 |
2000-09-13 |
ARTEMIS Pharmaceuticals GmbH |
Stable recombinant influenza viruses free of helper viruses
|
|
CA2365526C
(en)
|
1999-04-06 |
2016-07-05 |
Wisconsin Alumni Research Foundation |
Recombinant influenza viruses for vaccines and gene therapy
|
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
|
AU5998400A
(en)
|
1999-07-14 |
2001-01-30 |
Mount Sinai School Of Medicine Of The City University Of New York, The |
In vitro reconstitution of segmented negative-strand rna viruses
|
|
JP2003511037A
(ja)
|
1999-10-01 |
2003-03-25 |
ジェノボ， インコーポレイテッド |
ＡＡＶｒｅｐ／ｃａｐ遺伝子を含むアデノウイルスを使用する組換えＡＡＶの産生
|
|
US6686168B1
(en)
|
1999-11-04 |
2004-02-03 |
Zymogenetics, Inc. |
Cell surface display of proteins by recombinant host cells
|
|
US7192759B1
(en)
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
CA2395610A1
(en)
|
1999-12-30 |
2001-07-12 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for inhibiting adhesion by microorganisms
|
|
JP4698112B2
(ja)
|
2000-03-03 |
2011-06-08 |
一般財団法人化学及血清療法研究所 |
無血清培養かつ浮遊培養可能な細胞及び当該細胞を用いたワクチン用ウイルスの製造法
|
|
DE60143476D1
(de)
|
2000-04-14 |
2010-12-30 |
Wisconsin Alumni Res Found |
Mutiertes ionenkanalprotein enthaltende viren
|
|
AU2001259211B2
(en)
|
2000-04-28 |
2006-07-13 |
St. Jude Children's Research Hospital |
DNA transfection system for the generation of infectious influenza virus
|
|
US6358733B1
(en)
|
2000-05-19 |
2002-03-19 |
Apolife, Inc. |
Expression of heterologous multi-domain proteins in yeast
|
|
US20040241139A1
(en)
|
2000-07-20 |
2004-12-02 |
Gerd Hobom |
Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
EP1201760A1
(en)
|
2000-10-30 |
2002-05-02 |
ARTEMIS Pharmaceuticals GmbH |
Influenza virus vector for human dendritic cells
|
|
ATE433491T1
(de)
|
2001-01-18 |
2009-06-15 |
Vlaams Interuniv Inst Biotech |
Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential
|
|
EP1233059A1
(en)
|
2001-02-09 |
2002-08-21 |
ARTEMIS Pharmaceuticals GmbH |
Influenza viruses with enhanced transcriptional and replicational capacities
|
|
EP1364006A2
(en)
|
2001-02-23 |
2003-11-26 |
Wisconsin Alumni Research Foundation |
Methods to identify mutant cells with altered sialic acid
|
|
DE10144906B4
(de)
|
2001-09-12 |
2013-11-28 |
Novartis Vaccines And Diagnostics Gmbh |
Verfahren zur großtechnischen Herstellung von Impfstoffen
|
|
US7682618B2
(en)
|
2001-11-07 |
2010-03-23 |
The United States Of America As Represented By The Secretary Of The Army |
Generation of virus-like particles and use as panfilovirus vaccine
|
|
US20040057967A1
(en)
|
2001-11-07 |
2004-03-25 |
Sina Bavari |
Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
|
|
US6951752B2
(en)
|
2001-12-10 |
2005-10-04 |
Bexter Healthcare S.A. |
Method for large scale production of virus antigen
|
|
US7211378B2
(en)
|
2002-01-31 |
2007-05-01 |
Wisconsin Alumni Research Foundation |
Filovirus vectors and noninfectious filovirus-based particles
|
|
CA2816242C
(en)
|
2002-02-13 |
2019-01-08 |
Wisconsin Alumni Research Foundation |
Signal for packaging of influenza virus vectors
|
|
JP4430942B2
(ja)
|
2002-02-13 |
2010-03-10 |
ウィスコンシン・アルムナイ・リサーチ・ファウンデーション |
インフルエンザウイルスベクターのパッケージングのためのシグナル
|
|
AU2002239151A1
(en)
|
2002-03-08 |
2003-09-22 |
Crucell Holland B.V. |
Use of recombinant trypsin for vaccine production
|
|
FR2837497A1
(fr)
|
2002-03-22 |
2003-09-26 |
Univ Nantes |
Procede de production de vecteurs lentiviraux a haut titre
|
|
AU2003231083A1
(en)
|
2002-04-26 |
2003-11-10 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
US20050158342A1
(en)
|
2003-12-23 |
2005-07-21 |
Medimmune, Inc. |
Multi plasmid system for the production of influenza virus
|
|
WO2004042001A2
(en)
|
2002-05-17 |
2004-05-21 |
Emory University |
Virus-like particles, methods of preparation, and immonogenic compositions
|
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
EP2287288B1
(en)
|
2002-07-09 |
2012-11-07 |
Baxter International Inc. |
Animal protein free media for cultivation of cells
|
|
US6875433B2
(en)
|
2002-08-23 |
2005-04-05 |
The United States Of America As Represented By The Secretary Of The Army |
Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
|
|
US20040242518A1
(en)
|
2002-09-28 |
2004-12-02 |
Massachusetts Institute Of Technology |
Influenza therapeutic
|
|
US20040142322A1
(en)
|
2002-10-07 |
2004-07-22 |
Schering Corporation |
Continuous non-radioactive polymerase assay
|
|
EP1618191A2
(en)
|
2003-04-23 |
2006-01-25 |
Wisconsin Alumni Research Foundation |
Recombinant influenza viruses holding a mutation in a transmembrane protein gene
|
|
KR20060026854A
(ko)
|
2003-05-28 |
2006-03-24 |
위스콘신 얼럼나이 리서어치 화운데이션 |
ＰｏｌⅡ 프로모터 및 리보자임을 갖는 재조합 인플루엔자벡터
|
|
US8475806B2
(en)
|
2003-05-28 |
2013-07-02 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines and gene therapy
|
|
WO2005018539A2
(en)
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US20060240515A1
(en)
|
2003-07-21 |
2006-10-26 |
Dimitrov Dimiter S |
Soluble fragments of the SARS-CoV spike glycoprotein
|
|
US7037707B2
(en)
|
2003-09-04 |
2006-05-02 |
St. Jude Children's Research Hospital |
Method for generating influenza viruses and vaccines
|
|
US7279275B2
(en)
|
2003-11-03 |
2007-10-09 |
Washington University |
Methods and compositions for detection of segmented negative strand RNA viruses
|
|
JP2005245302A
(ja)
|
2004-03-04 |
2005-09-15 |
Kanazawa Univ Tlo Inc |
組換えインフルエンザウイルスおよびそれを用いたワクチン
|
|
US20060099609A1
(en)
|
2004-04-13 |
2006-05-11 |
Sina Bavari |
Activation of natural killer (NK) cells and methods of use
|
|
NZ551640A
(en)
|
2004-05-20 |
2010-05-28 |
Id Biomedical Corp |
Process for the production of an influenza vaccine
|
|
JP2008512443A
(ja)
|
2004-09-09 |
2008-04-24 |
カイロン ベーリング ゲーエムベーハー アンド カンパニー |
インフルエンザワクチンに関連する潜在的医原性リスクの減少
|
|
AU2005303817B8
(en)
|
2004-11-11 |
2010-09-30 |
Abbott Biologicals B.V. |
Defective influenza virus particles
|
|
AU2005337178A1
(en)
|
2004-11-19 |
2007-04-19 |
Wisconsin Alumni Research Foundation |
Recombinant influenza vectors with tandem transcription units
|
|
EP1831353B1
(en)
|
2004-12-23 |
2012-02-29 |
MedImmune, LLC |
Non-tumorigenic mdck cell line for propagating viruses
|
|
KR101272487B1
(ko)
|
2004-12-24 |
2013-06-07 |
에라스무스 유니버시티 메디컬 센터 로테르담 |
인플루엔자 바이러스의 구제
|
|
EP2471552B1
(en)
|
2005-03-08 |
2015-05-06 |
MedImmune, LLC |
Reassortant influenza viruses
|
|
BRPI0609362A2
(pt)
|
2005-04-11 |
2010-03-30 |
Us Gov Health & Human Serv |
vetor de adenovìrus recombinante, adenovìrus recombinante, composição imunogênica e método para a produção da referida composição imunogênica
|
|
FR2887958B1
(fr)
|
2005-07-01 |
2007-10-12 |
Prospection Et D Inv S Techniq |
Dispositif de reglage de commande de vanne pour appareil de fixation a gaz et l'appareil comportant le dispositif
|
|
NL1030161C2
(nl)
|
2005-10-11 |
2007-04-12 |
Matthijs Dirk Meulenbelt |
Presentatie-inrichting.
|
|
JP5349049B2
(ja)
|
2005-10-17 |
2013-11-20 |
メディミューン，エルエルシー |
インフルエンザウイルス製造用マルチプラスミド系
|
|
JP6087041B2
(ja)
|
2006-01-27 |
2017-03-08 |
ノバルティス アーゲー |
血球凝集素およびマトリックスタンパク質を含むインフルエンザウイルスワクチン
|
|
AU2007245192B2
(en)
|
2006-03-31 |
2012-04-12 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
AU2012204138B2
(en)
|
2006-03-31 |
2014-02-06 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
AU2014202470B2
(en)
|
2006-03-31 |
2016-08-04 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
JP5322636B2
(ja)
|
2006-05-11 |
2013-10-23 |
一般財団法人化学及血清療法研究所 |
インフルエンザウイルスの増殖方法
|
|
US20090017444A1
(en)
|
2006-06-09 |
2009-01-15 |
Wisconsin Alumni Research Foundation |
Screening method for modulators of viral transcription or replication
|
|
US7507411B2
(en)
|
2006-06-23 |
2009-03-24 |
University Of Saskatchewan |
Attenuated influenza NS1 variants
|
|
EP2049662A4
(en)
|
2006-07-21 |
2009-12-30 |
Medimmune Llc |
METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS
|
|
JP2010500034A
(ja)
|
2006-08-09 |
2010-01-07 |
メッドイミューン バクシーンズ，インコーポレイティド |
インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体
|
|
KR101464783B1
(ko)
|
2006-09-15 |
2014-11-26 |
메디뮨 엘엘씨 |
높은 역가로 바이러스 증식을 지원하는 ｍｄｃｋ 세포주 및 이를 이용한 생물반응기 공정
|
|
ES2480491T3
(es)
|
2006-12-06 |
2014-07-28 |
Novartis Ag |
Vacunas incluyendo antígeno de cuatro cepas de virus de la gripe
|
|
US8465960B2
(en)
|
2007-03-28 |
2013-06-18 |
Wisconsin Alumni Research Foundation |
Influenza B viruses with reduced sensitivity to neuraminidase inhibitors
|
|
WO2008125878A1
(en)
*
|
2007-04-16 |
2008-10-23 |
Bae Systems Plc |
Corrosion sensors
|
|
WO2008147496A2
(en)
|
2007-05-04 |
2008-12-04 |
Warf - Wisconsin Alumni Research Foundation |
Neuraminidase-deficient live influenza vaccines
|
|
WO2008156681A2
(en)
|
2007-06-14 |
2008-12-24 |
Yoshihiro Kawaoka |
Adenoviral vectors for influenza virus production
|
|
CA2690196A1
(en)
|
2007-06-18 |
2008-12-24 |
Medimmune, Llc |
Influenza b viruses having alterations in the hemaglutinin polypeptide
|
|
US9474798B2
(en)
|
2007-06-18 |
2016-10-25 |
Wisconsin Alumni Research Foundation |
Influenza M2 protein mutant viruses as live influenza attenuated vaccines
|
|
US8499329B2
(en)
|
2007-06-21 |
2013-07-30 |
Cisco Technology Inc. |
Power saving device
|
|
EA201070066A1
(ru)
|
2007-06-27 |
2010-06-30 |
Новартис Аг |
Вакцины против гриппа с низким содержанием добавок
|
|
EP2048237A1
(en)
|
2007-10-05 |
2009-04-15 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Replication deficient Influenza virus for the expression of heterologous sequences
|
|
US8084594B2
(en)
|
2007-07-13 |
2011-12-27 |
The United States Of America As Represented By The Secretary Of Agriculture |
H2N3 influenza A viruses and methods of use
|
|
WO2009049351A1
(en)
|
2007-10-15 |
2009-04-23 |
The University Of Queensland |
Construct system and uses therefor
|
|
WO2009128867A2
(en)
|
2008-01-07 |
2009-10-22 |
Warf - Wisconsin Alumni Research Foundation |
Recombinant biologically contained filovirus
|
|
US8163523B2
(en)
|
2008-06-11 |
2012-04-24 |
Flugen, Inc. |
Cell-based systems for producing influenza vaccines
|
|
CN102149405A
(zh)
|
2008-07-11 |
2011-08-10 |
米迪缪尼股份有限公司 |
流感血凝素和神经氨酸酶变体
|
|
CA2733589C
(en)
|
2008-08-08 |
2021-07-13 |
Ligocyte Pharmaceuticals, Inc. |
Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
|
|
US9222118B2
(en)
|
2008-11-07 |
2015-12-29 |
Wisconsin Alumni Research Foundation |
Screen for inhibitors of filovirus and uses therefor
|
|
MA33429B1
(fr)
|
2009-07-16 |
2012-07-03 |
Crucell Holland Bv |
Production de poliovirus à titres élevés pour la production de vaccins
|
|
WO2011014504A1
(en)
|
2009-07-27 |
2011-02-03 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza virus vectors and uses thereof
|
|
JP5845180B2
(ja)
|
2009-07-30 |
2016-01-20 |
モウント シナイ スクール オフ メディシネ |
インフルエンザウイルス及びそれらの使用
|
|
US8507247B2
(en)
|
2009-08-11 |
2013-08-13 |
Wisconsin Alumni Research Foundation |
Influenza A virus with attenuating mutations in NS2 protein
|
|
JP2013507990A
(ja)
*
|
2009-10-26 |
2013-03-07 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
|
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
KR101740019B1
(ko)
|
2009-11-10 |
2017-05-26 |
주식회사 팬택 |
무선통신시스템에서 시스템 정보 송수신 방법 및 그를 이용한 시스템 정보 송신장치와 수신장치
|
|
MX346257B
(es)
|
2009-11-23 |
2017-03-13 |
Wrigley W M Jun Co |
Bases de goma, gomas de mascar basadas en las mismas y métodos para hacerlas.
|
|
US20110159031A1
(en)
|
2009-12-22 |
2011-06-30 |
Baxter International Inc. |
Vaccine to Influenza A Virus
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
CN102939102A
(zh)
|
2010-04-09 |
2013-02-20 |
乌得勒支大学控股有限责任公司 |
重组多聚流感蛋白
|
|
EP3466440A1
(en)
|
2010-04-16 |
2019-04-10 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Chimpanzee adenoviral vector-based filovirus vaccines
|
|
GB201011502D0
(en)
|
2010-07-08 |
2010-08-25 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
WO2012033236A1
(ko)
|
2010-09-06 |
2012-03-15 |
에스케이케미칼 주식회사 |
무혈청 배양 및 부유 배양에 적응된 ｍｄｃｋ 세포주 및 상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
|
|
WO2012045882A2
(en)
|
2010-10-07 |
2012-04-12 |
Ac Immune S.A. |
Pharmaceutical composition
|
|
MX2013006234A
(es)
|
2011-01-06 |
2013-08-01 |
Univ Johns Hopkins |
Metodo para la produccion de glicoproteinas recombinantes con semivida en circulacion incrementada en celulas de mamifero.
|
|
CN103781901B
(zh)
|
2011-06-24 |
2019-04-12 |
复尔健有限公司 |
流感病毒突变体及其用途
|
|
JP2014527799A
(ja)
|
2011-08-26 |
2014-10-23 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
|
|
CN102304495A
(zh)
|
2011-09-08 |
2012-01-04 |
中国农业科学院上海兽医研究所 |
高效表达ha蛋白的重组流感病毒及其制备方法和应用
|
|
EP2820126B1
(en)
|
2012-03-02 |
2017-05-17 |
Seqirus UK Limited |
Influenza virus reassortment
|
|
JP2015527296A
(ja)
|
2012-03-26 |
2015-09-17 |
アメリカ合衆国 |
哺乳動物細胞へのパッケージングされたｒｎａの新規の送達
|
|
EA201590860A1
(ru)
|
2012-11-16 |
2015-11-30 |
МЕДИММЬЮН, ЭлЭлСи |
Варианты гемагглютинина и нейраминидазы вируса свиного гриппа
|
|
EP2970452A2
(en)
|
2013-03-15 |
2016-01-20 |
AC Immune S.A. |
Anti-tau antibodies and methods of use
|
|
HK1222882A1
(zh)
|
2013-06-06 |
2017-07-14 |
Novartis Ag |
流感病毒重配
|
|
EP3022296B1
(en)
|
2013-07-15 |
2022-12-28 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
|
|
CN106661569B
(zh)
|
2014-03-04 |
2020-09-11 |
西格马—奥尔德里奇有限责任公司 |
抗病毒细胞及其用途
|
|
EP3119883A4
(en)
|
2014-03-17 |
2018-01-10 |
Flugen, Inc. |
Influenza virus vectors and uses therefor
|
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
SG11201701506PA
(en)
|
2014-09-03 |
2017-03-30 |
Bavarian Nordic As |
Recombinant modified vaccinia virus ankara (mva) filovirus vaccine
|
|
CA2963470A1
(en)
|
2014-10-03 |
2016-04-07 |
Massachusetts Institute Of Technology |
Antibodies that bind ebola glycoprotein and uses thereof
|
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
|
WO2016144933A1
(en)
|
2015-03-10 |
2016-09-15 |
The Regents Of The University Of California |
Antibodies to the surface of toxoplasma gondii oocysts and methods of use thereof
|
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
|
EP3313439A2
(en)
|
2015-06-26 |
2018-05-02 |
Seqirus UK Limited |
Antigenically matched influenza vaccines
|
|
US9890363B2
(en)
|
2015-07-06 |
2018-02-13 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
|
US20170121391A1
(en)
|
2015-07-07 |
2017-05-04 |
Wisconsin Alumni Research Foundation (Warf) |
Potent glycoprotein antibody as a therapeutic against ebola virus
|
|
JP2018530314A
(ja)
|
2015-08-28 |
2018-10-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ウイルス様粒子からの感染性インフルエンザウイルスの生成
|
|
CN105296356A
(zh)
|
2015-12-02 |
2016-02-03 |
河南农业大学 |
一种刚地弓形虫卵囊的制备、纯化及保存方法
|
|
US10063211B2
(en)
|
2016-02-03 |
2018-08-28 |
Qualcomm Incorporated |
Compact bypass and decoupling structure for millimeter-wave circuits
|
|
JP2019510481A
(ja)
|
2016-02-19 |
2019-04-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ワクチン開発のための改善されたｂ型インフルエンザウイルス複製
|
|
JP2018064493A
(ja)
|
2016-10-19 |
2018-04-26 |
京都府公立大学法人 |
Ｍｄｃｋ細胞を用いたインフルエンザウイルスの増殖方法
|
|
EP3700562A1
(en)
|
2017-10-25 |
2020-09-02 |
Wisconsin Alumni Research Foundation (WARF) |
Recombinant influenza viruses with stabilized ha for replication in eggs
|
|
US12171821B2
(en)
|
2018-06-13 |
2024-12-24 |
Wisconsin Alumni Research Foundation (Warf) |
Toxoplasma gondii vaccine
|
|
JP7783047B2
(ja)
|
2018-08-07 |
2025-12-09 |
ウィスコンシン アルムニ リサーチ ファンデイション |
組換えの生物学的に封じ込められたフィロウイルスワクチン
|
|
EP3840780A1
(en)
|
2018-08-20 |
2021-06-30 |
Wisconsin Alumni Research Foundation |
Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (ha) protein
|
|
CN113423421A
(zh)
|
2018-09-21 |
2021-09-21 |
内布拉斯加大学董事会 |
制备和使用通用中心化流感疫苗基因的方法
|
|
EP3914295A2
(en)
|
2019-01-23 |
2021-12-01 |
Yoshihiro Kawaoka |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
US11851648B2
(en)
|
2019-02-08 |
2023-12-26 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
|
WO2020223699A1
(en)
|
2019-05-01 |
2020-11-05 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza virus replication for vaccine development
|
|
WO2020264141A1
(en)
|
2019-06-26 |
2020-12-30 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus neuraminidase and uses thereof
|
|
WO2021041624A2
(en)
|
2019-08-27 |
2021-03-04 |
Yoshihiro Kawaoka |
Recombinant influenza viruses with stabilized ha for replication in eggs
|
|
JP2023511444A
(ja)
|
2020-01-24 |
2023-03-17 |
ウィスコンシン アルムニ リサーチ ファンデイション |
安定化されたｎａを有する組換えインフルエンザウイルス
|
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
|
US12290562B2
(en)
|
2020-03-25 |
2025-05-06 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
WO2021242597A1
(en)
|
2020-05-23 |
2021-12-02 |
Wisconsin Alumni Research Foundation ("Warf") |
Ace2 expressing influenza virus
|
|
WO2022245888A1
(en)
|
2021-05-19 |
2022-11-24 |
Modernatx, Inc. |
Seasonal flu rna vaccines and methods of use
|
|
US20230321217A1
(en)
|
2021-09-28 |
2023-10-12 |
Yoshihiro Kawaoka |
Compositions comprising complexes displaying antigens and methods of using the compositions
|
|
WO2023125889A1
(en)
|
2021-12-31 |
2023-07-06 |
Suzhou Abogen Biosciences Co., Ltd. |
Quadrivalent mrna vaccines for influenza viruses
|
|
US20230346911A1
(en)
|
2022-02-23 |
2023-11-02 |
Wisconsin Alumni Research Foundation |
Broadly protective influenza b virus vaccines
|
|
WO2024015510A1
(en)
|
2022-07-13 |
2024-01-18 |
Wisconsin Alumni Research Foundation ("Warf") |
Sars-cov-2 lacking the envelope protein as an attenuated vaccine virus against covid-19
|
|
US20240238403A1
(en)
|
2022-11-16 |
2024-07-18 |
Wisconsin Alumni Research Foundation |
Influenza virus replication for vaccine development
|
|
WO2024197167A1
(en)
|
2023-03-21 |
2024-09-26 |
Wisconsin Alumni Research Foundation |
A cold-adapted, live attenuated sars-cov-2 vaccine
|